Voyager Therapeutics Announces Selection of Gene Therapy Development Candidate for Friedreich's Ataxia in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment
Stock Information for Voyager Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.